Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
Comvita Limited, together with its subsidiaries, engages in manufacturing and marketing natural health products in Australia, New Zealand, China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney and skincare, gourmet honey, elixirs and lozenges, and cider vinegar products, as well as...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is overvalued on EV/EBITDA, underpriced on P/FC.
Target Price
The average target price of CVT.NZ is 0.80 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell